Celon Pharma S.A. (WSE:CLN)
Poland
· Delayed Price · Currency is PLN 21.40
-0.20 (-0.93%)
At close: Mar 6, 2026
Celon Pharma Employees
Celon Pharma had 558 employees as of December 31, 2024. The number of employees increased by 43 or 8.35% compared to the previous year.
Employees
558
Change (1Y)
43
Growth (1Y)
8.35%
Revenue / Employee
398.58K PLN
Profits / Employee
-216.24K PLN
Market Cap
1.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 558 | 43 | 8.35% |
| Dec 31, 2023 | 515 | -8 | -1.53% |
| Dec 31, 2022 | 523 | 35 | 7.17% |
| Dec 31, 2021 | 488 | 21 | 4.50% |
| Dec 31, 2020 | 467 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| NEUCA | 4,445 |
| Synektik Spólka Akcyjna | 231 |
| Voxel | 323 |
| Selvita | 969 |
| Centrum Medyczne ENEL-MED | 1,200 |
| Ryvu Therapeutics | 328 |
| Captor Therapeutics Spolka Akcyjna | 91 |
| Scope Fluidics | 132 |
Celon Pharma News
- 1 year ago - Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL'36), a Novel Once-Daily Treatment of Levodopa-Induced Dyskinesia in Parkinson's Disease - Benzinga